Frequency and significance of rare RNF213 variants in patients with adult moyamoya disease

Purpose Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by stenosis of the internal carotid arteries with compensatory development of collateral vessels. Although a founder variant of RNF213, p.Arg4810Lys (c.14429G>A, rs112735431), is a major genetic risk factor for MMD in East Asians, the frequency and disease susceptibility of other variants in this gene remain largely unknown. In the present study, we investigated the association of RNF213 variants with MMD in Korean patients and population controls. Methods For all RNF213 variants listed in the Human Gene Mutation Database (HGMD) as disease-causing or likely disease-causing mutations for MMD, genotyping was performed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Genetic data from 264 adult patients with MMD were analyzed and compared with two control populations comprised of 622 and 1,100 Korean individuals, respectively. Results Among the 30 RNF213 variants that were listed in the HGMD, p.Arg4810Lys was identified in 67.4% (178/264) of patients with MMD and showed a significantly higher allele frequency than in the controls, giving an odds ratio of 63.29 (95% confidence interval, 33.11–120.98) for the 622 controls and 48.55 (95% confidence interval, 31.00–76.03) for the 1100 controls. One additional variant, p.Ala5021Val (c.15062C>T, rs138130613), was identified in 0.8% (2/264) of patients; however, the allele frequencies were not significantly different from those in the controls. Conclusions These results suggest that, in our cohort of Korean patients, the p.Arg4810Lys is the only variant that is strongly associated with MMD among the 30 RNF213 variants listed in the HGMD.

[1]  Kai Wang,et al.  Mutation genotypes of RNF213 gene from moyamoya patients in Taiwan , 2015, Journal of the Neurological Sciences.

[2]  T. Nariai,et al.  Systematic Validation of RNF213 Coding Variants in Japanese Patients With Moyamoya Disease , 2015, Journal of the American Heart Association.

[3]  T. Tominaga,et al.  Enhanced post-ischemic angiogenesis in mice lacking RNF213; a susceptibility gene for moyamoya disease , 2015, Brain Research.

[4]  T. Nariai,et al.  Systematic Validation of RNF 213 Coding Variants in Japanese Patients With Moyamoya Disease , 2015 .

[5]  Gao T. Wang,et al.  RNF213 Rare Variants in an Ethnically Diverse Population With Moyamoya Disease , 2014, Stroke.

[6]  Qiang Li,et al.  Serum miRNA Signature in Moyamoya Disease , 2014, PloS one.

[7]  Seung-Chyul Hong,et al.  High-Resolution Magnetic Resonance Wall Imaging Findings of Moyamoya Disease , 2014, Stroke.

[8]  H. Ahn,et al.  Incidence, Prevalence, and Survival of Moyamoya Disease in Korea: A Nationwide, Population-Based Study , 2014, Stroke.

[9]  S. Roman,et al.  Loss of α1β1 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia. , 2014, American journal of human genetics.

[10]  P. Stenson,et al.  The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine , 2013, Human Genetics.

[11]  S. Miyamoto,et al.  Rapid Progression of Unilateral Moyamoya Disease in a Patient with a Family History and an RNF213 Risk Variant , 2013, Cerebrovascular Diseases.

[12]  Lu Ma,et al.  RNF213 polymorphism and Moyamoya disease: A systematic review and meta-analysis. , 2013, Neurology India.

[13]  M. Guan,et al.  Molecular Analysis of RNF213 Gene for Moyamoya Disease in the Chinese Han Population , 2012, PloS one.

[14]  Y. Kuroiwa,et al.  Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease , 2012, Neurology.

[15]  L. Regli,et al.  Regional differences in incidence and patient characteristics of moyamoya disease: a systematic review , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[16]  A. Fujiyama,et al.  Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development , 2011, PloS one.

[17]  S. Gazal,et al.  Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya. , 2011, American journal of human genetics.

[18]  A. Hata,et al.  A genome-wide association study identifies RNF213 as the first Moyamoya disease gene , 2011, Journal of Human Genetics.

[19]  Robert K. Yu,et al.  Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. , 2009, American journal of human genetics.

[20]  P. Vajkoczy,et al.  Increased Levels of Circulating Endothelial Progenitor Cells in Patients With Moyamoya Disease , 2009, Stroke.

[21]  S. Kuroda,et al.  Moyamoya disease: current concepts and future perspectives , 2008, The Lancet Neurology.

[22]  S. Kuroda,et al.  Novel epidemiological features of moyamoya disease , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[23]  M. Fukui,et al.  A novel susceptibility locus for moyamoya disease on chromosome 8q23 , 2004, Journal of Human Genetics.

[24]  M. Fukui,et al.  Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. , 1999, American journal of human genetics.

[25]  Y. Yonekawa,et al.  Moyamoya disease in Europe, past and present status , 1997, Clinical Neurology and Neurosurgery.